Status:
TERMINATED
Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery
Lead Sponsor:
Prisma Health-Upstate
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18-80 years
Phase:
PHASE4
Brief Summary
This is a randomized controlled pilot study evaluating length of pain control with either liposomal bupivacaine or with bupivacaine plus decadron after PEC II injection in patients having bilateral ma...
Detailed Description
This research hopes to determine the duration of patient-reported analgesia provided by ultrasound guided PEC II field block injections. The design of the study randomly assigns the side of injection ...
Eligibility Criteria
Inclusion
- Scheduled for bilateral mastectomy
Exclusion
- allergy to local anesthetics, prior breast surgery, asymmetric surgical plan
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03383198
Start Date
December 1 2017
End Date
August 30 2019
Last Update
November 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patewood Memorial Hospital
Greenville, South Carolina, United States, 29615